Results 51 to 60 of about 273,643 (353)
BACKGROUND: Elevated serum cardiac troponin T (cTnT) and I (cTnI) can occur in patients with chronic kidney disease. Differences in cTn concentrations between cTnT and cTnI have been reported but the mechanism of such discrepancy has not been ...
Collinson, PO +5 more
core +1 more source
Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis
The aim of this study was to evaluate the diagnostic utility of high‐sensitivity cardiac troponin T (hs‐cTnT) levels in discriminating cardiac amyloidosis from patients with cardiac hypertrophy caused by aetiologies other than cardiac amyloidosis.
S. Takashio +13 more
semanticscholar +1 more source
Background: This systematic review describes the prognostic value of postoperative cardiac high-sensitive troponin I and T as risk markers for major adverse cardiac events (MACE) after coronary artery bypass graft (CABG) surgery and their predictive ...
Maaike S.Y. Thio +7 more
doaj +1 more source
Cardiac troponins in intensive care
The cardiac troponins are integral components of the myofibrillary apparatus and they regulate muscle contraction. The measurement of cardiac troponins has replaced other biomarkers for the specific detection of myocardial necrosis and for the diagnosis ...
Collinson, P.O. +3 more
core +1 more source
Release and Clearance Mechanisms of Cardiac Troponin [PDF]
Myocardial infarction (MI) is often suspected when a patient presents with chest pain. MI is defined as cardiac necrosis due to ischemia, most often mediated through impaired coronary perfusion.
Karin, Starnberg
core +1 more source
Background: While troponin is an established biomarker of cardiac injury, its prognostic significance in post-cardiotomy cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation (PCCS–VA-ECMO) remains unclear.
Małgorzata Celińska-Spodar +6 more
doaj +1 more source
Development of the Cardiac Troponin T Immunoassay [PDF]
Featured Article: Katus HA, Looser S, Hallermayer K, Remppis A, Scheffold T, Borgya A, et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem 1992;38:386–93.1 This paper was the first report on the development and analytical characterization of an immunoassay for cardiac troponin T (cTnT)2 that was ...
openaire +2 more sources
STUDY OBJECTIVE We aim to prospectively validate the diagnostic accuracy of the recently developed 0-h/1-h algorithm, using high-sensitivity cardiac troponin T (hs-cTnT) for the early rule-out and rule-in of acute myocardial infarction.
C. Mueller +16 more
semanticscholar +1 more source
Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito +8 more
wiley +1 more source
Rhabdomyolysis: A Noncardiac Source of Increased Circulating Concentrations of Cardiac Troponin T?
Cardiac troponin T (cTnT) and cardiac troponin I (cTnI) are regarded as equivalent in the diagnosis of acute myocardial infarction (AMI) [(1)][1], as they correlate closely with each other and show very high and comparable diagnostic accuracies [(2)][2].
J. du Fay de Lavallaz +9 more
semanticscholar +1 more source

